Efg Asset Management (Americas) Corp. Dexcom Inc Transaction History

Efg Asset Management (Americas) Corp.

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	SELL	$114.22 - $140.1 $115,247 - $141,360	-1,009 Reduced 37.36%	1,692 $234,000
Q4 2023 Feb 01, 2024	SELL	$75.49 - $124.16 $51,484 - $84,677	-682 Reduced 20.16%	2,701 $335,000
Q3 2023 Nov 09, 2023	SELL	$86.06 - $137.93 $8,606 - $13,793	-100 Reduced 2.87%	3,383 $315,000
Q2 2023 Aug 29, 2023	SELL	$112.47 - $130.98 $44,538 - $51,868	-396 Reduced 10.21%	3,483 $447,000
Q1 2023 May 04, 2023	SELL	$104.0 - $122.92 $30,056 - $35,523	-289 Reduced 6.93%	3,879 $450,000
Q4 2022 Feb 09, 2023	SELL	$84.98 - $122.67 $37,731 - $54,465	-444 Reduced 9.63%	4,168 $471,000
Q2 2022 Jul 13, 2022	BUY	$67.99 - $132.89 $234,769 - $458,869	3,453 Added 297.93%	4,612 $344,000
Q1 2022 May 05, 2022	BUY	$94.08 - $130.2 $9,502 - $13,150	101 Added 9.55%	1,159 $593,000
Q4 2021 Jan 24, 2022	BUY	$129.87 - $162.82 $1,948 - $2,442	15 Added 1.44%	1,058 $568,000
Q3 2021 Oct 22, 2021	SELL	$106.71 - $143.18 $3,521 - $4,724	-33 Reduced 3.07%	1,043 $570,000
Q2 2021 Jul 23, 2021	BUY	$80.99 - $107.93 $17,979 - $23,960	222 Added 26.0%	1,076 $459,000
Q1 2021 Apr 09, 2021	BUY	$84.79 - $104.74 $19,671 - $24,299	232 Added 37.3%	854 $307,000
Q4 2020 Feb 05, 2021	BUY	$78.0 - $104.5 $4,134 - $5,538	53 Added 9.31%	622 $230,000
Q3 2020 Nov 06, 2020	BUY	$95.51 - $112.95 $54,345 - $64,268	569 New	569 $235,000
Q4 2017 Feb 07, 2018	SELL	$11.12 - $15.38 $64,318 - $88,957	-5,784 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$11.36 - $18.98 $16,687 - $27,881	1,469 Added 34.04%	5,784 $283,000
Q2 2017 Aug 14, 2017	BUY	N/A	4,315	4,315 $316,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $28.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Efg Asset Management (Americas) Corp., based on Form 13F filings with the SEC.

Stay updated on Efg Asset Management (Americas) Corp. with notifications on news.